Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Sandra Jernström,1,2 Vesa Hongisto,3 Suvi-Katri Leivonen,1,2 Eldri Undlien Due,1 Dagim Shiferaw Tadele,1 Henrik Edgren,4,5 Olli Kallioniemi,4 Merja Perälä,6 Gunhild Mari Mælandsmo,2,7,8 Kristine Kleivi Sahlberg,1,9 1Department of Cancer Genetics, Institute for Ca...

Full description

Bibliographic Details
Main Authors: Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Breast Cancer : Targets and Therapy
Subjects:
ERBB2
drug screening
gene expression
pharmacogenomics
predictors
Online Access:https://www.dovepress.com/drug-screening-and-genomic-analyses-of-her2-positive-breast-cancer-cel-peer-reviewed-article-BCTT

Internet

https://www.dovepress.com/drug-screening-and-genomic-analyses-of-her2-positive-breast-cancer-cel-peer-reviewed-article-BCTT

Similar Items